The Impact of the Withdrawal of SGLT2 Inhibitors on Clinical Outcomes in Patients with Heart Failure

Keyphrases

• All-cause Readmission 50%
• Clinical Impact 10%
• Clinical Outcomes 100%
• Consecutive Patients 10%
• Heart Failure 10%
• Hospitalization 20%
• Medical Costs 20%
• No Significant Difference 10%
• Patients with Heart Failure 100%
• Prognostic Impact 10%
• Readmission Rates 10%
• Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i) 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Congestive Heart Failure 100%
• Cotransporter 100%
• Sodium Glucose Cotransporter 2 Inhibitor 100%